Molecular Diagnostics Market Size Report | Growth Forecasts to 2030
[Research Report] The molecular diagnostics market was valued at US$ 18,173.87 million in 2022 and the molecular diagnostics market size is projected to reach US$ 45,875.65 million by 2030. It is expected to register a CAGR of 12.3% during the forecast period.
Market Insights and Analyst View:
Molecular diagnostics procedures can be employed in the detection of a wide range of conditions such as oncologic diseases, infectious diseases, cardiac diseases, and immune system disorders; they can also be used in genetic testing using genetic material such as DNA and RNA for the diagnosis of different diseases. Development of new products and increase in demand for point-of-care testing and surging prevalence of associated diseases. However, limitations associated with molecular testing hinders the growth of the molecular diagnostics market.
Growth Drivers and Opportunities:
Development of New Products and Increase in Demand for Point-of-Care Testing
Leading medical device manufacturers and other businesses operational in associated markets are actively involved in product innovation and development processes. A few of such important developments in the molecular diagnostics market are mentioned below.
Month & Year | Description |
July 2021 | Abbott launched its Panbio COVID-19 rapid antigen tests in India. |
July 2021 | Siemens Healthineers commenced the manufacturing of IMDX SARS-CoV2 and other molecular diagnostic kits in its Vadodara (India) facility. |
July 2021 | Bio-Rad Laboratories, Inc. launched Reliance SARS-CoV-2/FluA/FluB RT-PCR Kit for in vitro diagnosis. The kit contains standard and negative molecular controls, along with assay reagents. It is validated to run on Bio-Rad's CFX96 Dx real-time PCR system, in addition to other real-time PCR systems of other manufacturers. |
September 2021 | Chembio Diagnostics, Inc. submitted the Emergency Use Authorization (EUA) application to the Food and Drug Administration (FDA) for its DPP Respiratory Antigen Panel Test System. It is designed to facilitate the simultaneous, discrete, and differential detection of influenza A, influenza B, and SARS-CoV-2 antigens, among others, from a single patient's nasal swab sample. |
September 2021 | Agilent Technologies Inc. signed a worldwide distribution agreement with Visiopharm, which enables Agilent to co-market Visiopharm’s portfolio of CE-IVD marked artificial intelligence (AI)-driven precision pathology software in addition to its own portfolio of automated pathology staining solutions. |
October 2021 | Siemens Healthineers launched the CLINITEST Rapid COVID-19 Test, a rapid antigen test that produces results within 15 minutes. |
December 2020 | Thermo Fisher Scientific acquired Phitonex, Inc., a company based in Durham (North Carolina) that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology, and immunology. Phitonex's product offering would enable Thermo Fisher to offer better flow cytometry and imaging multiplexing capabilities to meet evolving customer needs in protein and cell analysis research. |
Source: The Partners Analysis
Point-of-care testingv is a branch of medicine with a rapidly evolving analytical scope and clinical application. Point-of-care testing solution providers offer products for various evaluations, ranging from blood glucose measurement to viscoelastic coagulation assays. Eliminating the time of transportation and preparation of clinical samples, these tests enable professionals to make clinical decisions about additional testing or therapy in less time. This emerging healthcare solution is being aggressively adopted by patients and healthcare service providers. Point-of-care assays are extensively used in therapeutics, diagnostics, and patient monitoring applications, among others. Moreover, point-of-care products and services help healthcare providers in meeting patients’ demand for at-home medical care. These products and services proved specifically helpful during the COVID-19 pandemic by allowing patients to take tests from their homes instead of traveling to diagnostic or treatment facilities, thereby lowering the risk of infection. Thus, the rising demand for point-of-care testing benefits the molecular diagnostics market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Molecular Diagnostics Market: Strategic Insights
Market Size Value in US$ 18,173.87 million in 2022 Market Size Value by US$ 45,875.65 million by 2030 Growth rate CAGR of 12.3% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Molecular Diagnostics Market: Strategic Insights
| Market Size Value in | US$ 18,173.87 million in 2022 |
| Market Size Value by | US$ 45,875.65 million by 2030 |
| Growth rate | CAGR of 12.3% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Advancements in Molecular Diagnostics Technologies
Molecular diagnostic techniques and platforms are being used in all areas of anatomic and clinical pathologies. DNA or RNA sequences that are associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected in molecular diagnostic tests. Molecular diagnosis has undergone further improvements after the emergence of COVID-19. Conventionally, CT scans, hematological tests, and RT-PCR were in use for testing. As COVID-19 cases grew rapidly in 2020, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Computed tomography (CT), a cost-intensive procedure that may not be available in all hospitals, fails to detect viral infections and other diseases in asymptomatic patients. RT-PCR, which was widely used, was also time-consuming and expensive, and was unable to detect a low viral load during the early stages of infection. Consequently, researchers developed novel approaches to detect SARS-CoV-2, which were faster and more cost effective. Reverse transcription loop-mediated isothermal amplification (RT-LAMP), microarray-based detection, aptamer-based diagnosis, SHERLOCK, SHERLOCKv2, FET Biosensors, cell-based potentiometric diagnosis, and molecular imprinting technology are a few of the examples of novel molecular diagnostics techniques developed for COVID-19 diagnosis. In the last few years, FDA reports have indicated that advancements in molecular testing, antigen-dependent testing, and serological testing have been approved. Collaborative efforts by scientific communities in different countries to manage the COVID-19 pandemic and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which is likely to create significant opportunities for the molecular diagnostics market in the future.
Report Segmentation and Scope:
The “Global Molecular Diagnostics Market” is segmented into disease area, technology, product and services, end user, and geography. Based on disease area, the molecular diagnostics market is segmented into oncology, infectious disease, genetic testing, cardiac diseases, immune system disorders, and others. Based on technology, the molecular diagnostics market is segmented into polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & Next-Generation sequencing, DNA microarrays, in-situ hybridization, and others. Based on product & services, the molecular diagnostics market is segmented into assays & kits, instruments, and services & software. Based on end user, the molecular diagnostics market is segmented into hospitals & clinics, diagnostic laboratories, research & academic institutions, and others. Geographically, the molecular diagnostics market is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Segmental Analysis:
Based on technology, the molecular diagnostics market is segmented into polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & Next-Generation sequencing, DNA microarrays, in-situ hybridization, and others. The PCR is further sub segmented into RT-PCR, qPCR, Multiplex PCR, and others. The PCR segment held the largest share of the market in 2022, and the same segment is anticipated to register the highest CAGR of 12.7% in the market during the forecast period. PCR is mainly used to make or amplify DNA by copying the nucleic acid strands. Thermal cyclers are employed to denature and anneal DNA strands during amplification, along with reagents such as enzymes, nucleotides, and buffers to build the novel DNA. This technique is widely used in various application such as functional analysis of genes, diagnosis of hereditary, DNA cloning, paternity testing, detection of infectious diseases, and forensic sciences. Polymerase chain reaction has been classified into traditional PCR, real-time PCR, and digital PCR. However, ongoing technological advances and surging demand amid the pandemic will continue to fuel the need for PCR tests in India as well as other Asia Pacific countries. Consistent prevalence of diseases like tuberculosis, Hepatitis, flu, and serious infections will foster PoC molecular diagnostic industry trends. Presently, the outbreak of novel COVID-19 pandemic would create lucrative growth aspects for the market as this approach is highly critical to detect virus in individuals who exhibit no symptoms of signs of disease. PCR’s exquisite sensitivity, relative simplicity, and cost-effectiveness makes PCR stand apart from other nucleic acid amplification techniques, cementing it as a mainstay in molecular laboratories.PCRPCRPCR has become an indispensable tool for various clinical and diagnostic applications or examinations due to continuous research & development on PCR technologies. Therefore, it offers many opportunities for rapid point-of-care diagnostics for various infectious diseases. For instance, F. Hoffmann-La Roche Ltd is continuously working on the advancements of Digital PCR (dPCR) techniques. dPCR has extended its applications to the clinical field and has emerged as an important clinical tool. dPCR offers ultrasensitive and absolute nucleic acid quantification without reference standard. Thus, it offers a broader aspect for standardizing and comparing results between laboratories.During pandemic outbreak, one of the first mover startup, Mylab PathoDetect COVID-19 Qualitative PCR kit was among the first in the country to receive commercial approval from the Central Drugs Standard Control Organisation (CDSCO) last year. Following the approval, Mylab had partnered with biotech giant Serum Institute of India and local firm AP Globale. PCR is further sub-segmented into RT-PCR, qPCR, multiplex PCR and others.
Based on disease area, the molecular diagnostics market is segmented into oncology, infectious disease, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment held the largest market share in 2022. However, oncology segment is anticipated to register the highest CAGR of 12.6% during the forecast period. Oncology molecular diagnostics are tests that expose inherited material, proteins, associated molecules and assess metabolic functions, drug metabolism, and disease induction grounded on DNA, RNA, and proteins that deliver oncological information. As stated by World Health Organization (WHO), cancer reckoned for roughly 10 million demises in 2020. Furthermore, as per the 2021 statistics by the American Cancer Society, by 2040, the global burden of carcinoma is anticipated to raise to 27.5 million fresh cases and 16.3 million cancer deceases. Such like high figures denote that the evaluated rising frequency of cancer is chipping into the accelerating requirement for primitive diagnosis and preventive cure. There are numerous methods to diagnose carcinoma comprehending PCR, INAAT, and NGS etc. Among all the conception of PCR (polymerase chain reaction) led to an enormous advancement in clinical DNA testing. PCR-based methodologies demand straightforward instrumentation and infrastructure, exploit only minute quantities of biological material and are extensively harmonious with clinical routine.
Although the cost of PCR is lofty, most accurate real-time PCR approach (with more than 99% accuracy) is the one substantially used in numerous developed countries including Korea, while developing countries substantially exploit the conventional PCR (more than 90% accuracy), which is affordable than real-time PCR. Because of the high prices of the other options, underdeveloped countries generally use Rapid PCR (60 – 70% accuracy). Within the field of oncology molecular diagnostics, NGS is another technology flaunting the loftiest rate of growth. Numerous companies are working intensely to make economic use of this technology. For instance, in April 2021, Illumina Inc. blazoned its partnership with Kartos Therapeutics to co-develop an NGS- Based TP53 Companion Diagnostic, which aided to reduce the costs associated with storing and managing of genomic data.
Based on product & services, the molecular diagnostics market is segmented into assays & kits, instruments, and services & software. The assays & kits segment held the largest share of the market in 2022, and it is anticipated to register the highest CAGR in the market during the forecast period. Molecular Diagnostics assays are among the widely used technique for analysis. Various types of assays such as rapid molecular assays, reverse transcription-polymerase chain reaction (RT-PCR), antigens, and others are used to identify and analyse various diseases such as influenza COVID 19, tuberculosis, and others. As part of product innovation and business strategies, the market players offer diagnostic kits for different test kits. The regional players are actively involved in business development related to the segment. For instance, In September 2021, Mylab Discovery Solutions acquired a majority stake in Sanskritech, developer of a platform Swayam a point of care testing system that can perform about 70 tests on the point. Moreover, in the COVID19 pandemic, various global market players offer their kits through their regional business divisions. Based on the above factors, the segment is expected to contribute remarkably during the forecast period.
Based on end user, the molecular diagnostics market is segmented into hospitals & clinics, diagnostic laboratories, research & academic institutions, and others. In 2022, the diagnostic laboratories segment held the largest share of the market. Moreover, the segment is also expected to witness growth in its demand at a fastest CAGR of 12.7% during 2022 to 2030, owing to the rise in the detection and diagnosis of various medical conditions across the regions. Diagnostic laboratories are the primary uses for molecular diagnostics products and services. It has well-established facilities as per the regulatory requirements. The laboratories use all possible molecular diagnostic products and services. The sample collected from the patients is analyzed and studied using different instruments, reagents, methods, and technologies. The labs provide services to hospitals, clinics, at-home care, and others. The increasing prevalence of chronic diseases, infectious diseases, outsourcing the molecular diagnostics activities by individual researchers are among the factors supporting the segment growth during the forecast period.
Regional Analysis:
Geographically, the molecular diagnostics market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North America regional market is expected to grow at a CAGR of 12.5% during the forecast period. The same region held the largest share in 2022 and is expected to continue a similar trend during the forecast period.
The increasing adoption of technologically advanced products, rise in research & development activities, presence of large healthcare businesses, and growing use of molecular diagnostics are among the key factors propelling the growth of the molecular diagnostics market in this region. The US held the largest share of the North America molecular diagnostics market in 2022.
The US holds the largest share of the molecular diagnostics market. Market growth in this country is primarily driven by the increasing prevalence of chronic kidney disorders (CKD), rising geriatric population, and a growing number of product launches by key players. Aging is a prominent risk factor responsible for renal diseases. According to a study published by the Population Reference Bureau in 2020, the population of individuals of age 65 years was 55 million in the US in 2020, which is expected to reach 95 million by 2060. Regulatory agencies in the US are devising favourable policies for the development of point-of-care (POC) products for the diagnosis and treatment of various indications. For instance, in March 2021, the US Food Drug Administration (FDA) authorized the first point of care testing of Chlamydia and Gonorrhea Test by the usage of Binx Health IO CT/NG Assay for point-of-care settings such as community-based clinics, urgent care settings, and outpatient healthcare facilities. In May 2022, BD (Becton and Dickinson), one of the leading global medical technology companies, announced the launch of its new, fully automated, high-throughput infectious disease molecular diagnostics platform in the US. The new BD COR MX instrument, with the 510(k) clearance from the FDA, is a new analytical instrument option for the BD COR platform. The BD CTGCTV2 molecular assay, the first test available on the new system, a single test that detects the three most prevalent non-viral sexually transmitted infections (STIs)—Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).
The growth of the market in Asia Pacific is attributed to rising geriatric population, increasing cancer cases, growing technological advancements, and increasing number of startups, biotechnology, and biopharmaceutical companies are driving the molecular diagnostics market in this region. Moreover, the rise in research activities in the region and the presence of associations or organizations enhancing the quality of care in cancer contribute to the molecular diagnostics market growth.
Molecular Diagnostics Market Report Scope
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global molecular diagnostics market are listed below:
- In April 2023, QIAGEN launched QIAstat-Dx in Japan with respiratory panel for syndromic testing. Japan to become the latest of more than 100 countries where QIAstat-Dx is available for molecular testing in diagnosing over 20 respiratory diseases from one patient sample.
- In April 2023, Novartis Malaysia extended the Molecular Diagnosis Program for aBC patients with PIK3CA Gene. This will create the accessibility of PIK3CA testing, realizing the significant impact of early diagnosis and intervention on advanced breast cancer (aBC) patient’s quality of life.
- In January 2023, Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test. The agreement between Quest and Agilent will enable broad adoption for ctDx FIRST, a single-site premarket approved (ssPMA) test performed at the Resolution Bioscience CLIA laboratory in Washington.
- In February 2023, Siemens Healthineers announced a multi-year partnership with Unilabs. This partnership will improve the patient care and also installation of various instruments by Siemens.
COVID-19 Impact:
Before the COVID-19 pandemic, molecular diagnostics market was experiencing a steady increase in demand before the COVID-19 pandemic. Technological advancements, like a polymerase chain reaction (PCR), and others, the rising application of molecular diagnostics were growing before pandemic.
During pandemic, the spread of the pandemic coupled with uncertainty around economic recovery has affected the pharmaceutical industry in the region. This economic impact is expected to have negative effect on the investments in research and development. Some key players in the molecular diagnostics provided best postop operative care to their cancer patient while protecting health care professionals and other patients. Abbott has received Emergency Use Authorization (EUA) for a point-of-care test that can provide results in minutes. Thus, increased production by the companies has resulted in profits, and the outbreak of COVID-19 has shown a positive impact on market growth.
Competitive Landscape and Key Companies:
Some of the prominent players operating in the global molecular diagnostics market are Abbott Laboratories, Agilent Technologies Inc., Thermo Fisher Scientific Inc, F. Hoffman-La Roche Ltd., Qiagen NV, bioMerieux SA, Illumnia Inc., Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their market share. The report offers trend analysis of the molecular diagnostics market emphasizing various parameters such as technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Disease Area, Technology, Product & Services, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Based on technology, the molecular diagnostics market is segmented into polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & Next-Generation sequencing, DNA microarrays, in-situ hybridization, and others. The PCR is further sub segmented into RT-PCR, qPCR, Multiplex PCR, and others. The PCR segment held the largest share of the market in 2022, and the same segment is anticipated to register the highest CAGR during the forecast period.
Companies operating in the market are Abbott Laboratories, Agilent Technologies Inc., Thermo Fisher Scientific Inc, F. Hoffman-La Roche Ltd., Qiagen NV, bioMerieux SA, Illumnia Inc., Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited.
Global molecular diagnostics market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the molecular diagnostics market during 2022–2030. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.
Molecular diagnostics procedures can be employed in the detection of a wide range of conditions such as oncologic diseases, infectious diseases, cardiac diseases, and immune system disorders; they can also be used in genetic testing using genetic material such as DNA and RNA for the diagnosis of different diseases.
Based on disease area, the molecular diagnostics market is segmented into oncology, infectious disease, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment held the largest market share in 2022. However, oncology segment is anticipated to register the highest CAGR during the forecast period.
Development of new products and increase in demand for point-of-care testing and surging prevalence of associated diseases. are the key driving factors behind the market development.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Molecular Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
5. Molecular Diagnostics Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:
6. Molecular Diagnostics Market - Global Market Analysis
6.1 Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. Global Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Disease Area
7.1 Overview
7.2 Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
7.4.1 Overview
7.4.2 Infectious Disease: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
7.5.1 Overview
7.5.2 Genetic Testing: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
7.6.1 Overview
7.6.2 Cardiac Diseases: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
7.7.1 Overview
7.7.2 Immune System Disorders: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Technology
8.1 Overview
8.2 Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 PCR: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 RT-PCR
8.3.2.1.1 Overview
8.3.3 RT-PCR: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.3.1 qPCR
8.3.3.1.1 Overview
8.3.4 PCR: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.4.1 Multiplex PCR
8.3.4.1.1 Overview
8.3.5 Multiplex PCR: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.5.1 Others
8.3.5.1.1 Overview
8.3.6 Others: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
8.5.1 Overview
8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
8.6.1 Overview
8.6.2 DNA Microarrays: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
8.7.1 Overview
8.7.2 In-Situ Hybridization (ISH): Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services
9.1 Overview
9.2 Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
9.3.1 Overview
9.3.2 Assays and Kits: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
9.4.1 Overview
9.4.2 Instruments: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
9.5.1 Overview
9.5.2 Services and Software: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Global Molecular Diagnostics Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
10.4.1 Overview
10.4.2 Diagnostics Laboratories: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. Molecular Diagnostics Market - Geographical Analysis
11.1 North America Molecular Diagnostics Market, Revenue And Forecast To 2030
11.1.1 Overview
11.1.2 North America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America Molecular Diagnostics Market, by Disease Area
11.1.4 North America Molecular Diagnostics Market, by Technology
11.1.4.1 North America Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
11.1.5 North America Molecular Diagnostics Market, by Product and Services
11.1.6 North America Molecular Diagnostics Market, by End User
11.1.6.1 North America Molecular Diagnostics Market, by Country
11.1.7 US
11.1.7.1 Overview
11.1.8 US Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.9 US Molecular Diagnostics Market, by Disease Area
11.1.10 US Molecular Diagnostics Market, by Technology
11.1.10.1 US Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
11.1.11 US Molecular Diagnostics Market, by Product and Services
11.1.12 US Molecular Diagnostics Market, by End User
11.1.13 Canada
11.1.13.1 Overview
11.1.14 Canada Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.15 Canada Molecular Diagnostics Market, by Disease Area
11.1.16 Canada Molecular Diagnostics Market, by Technology
11.1.16.1 Canada Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.17 Canada Molecular Diagnostics Market, by Product and Services
11.1.18 Canada Molecular Diagnostics Market, by End User
11.1.19 Mexico
11.1.19.1 Overview
11.1.20 Mexico Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.21 Mexico Molecular Diagnostics Market, by Disease Area
11.1.22 Mexico Molecular Diagnostics Market, by Technology
11.1.22.1 Mexico Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.23 Mexico Molecular Diagnostics Market, by Product and Services
11.1.24 Mexico Molecular Diagnostics Market, by End User
11.2 Europe Molecular Diagnostics Market, Revenue And Forecast to 2030
11.2.1 Overview
11.2.2 Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe Molecular Diagnostics Market, by Disease Area
11.2.4 Europe Molecular Diagnostics Market, by Technology
11.2.4.1 Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.5 Europe Molecular Diagnostics Market, by Product and Services
11.2.6 Europe Molecular Diagnostics Market, by End User
11.2.6.1 Europe Molecular Diagnostics Market by Country
11.2.7 Germany
11.2.7.1 Overview
11.2.8 Germany Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.9 Germany Molecular Diagnostics Market, by Disease Area
11.2.10 Germany Molecular Diagnostics Market, by Technology
11.2.10.1 Germany Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.11 Germany Molecular Diagnostics Market, by Product and Services
11.2.12 Germany Molecular Diagnostics Market, by End User
11.2.13 UK
11.2.13.1 Overview
11.2.14 UK Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.15 UK Molecular Diagnostics Market, by Disease Area
11.2.16 UK Molecular Diagnostics Market, by Technology
11.2.16.1 UK Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.17 UK Molecular Diagnostics Market, by Product and Services
11.2.18 UK Molecular Diagnostics Market, by End User
11.2.19 France
11.2.19.1 Overview
11.2.20 France Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.21 France Molecular Diagnostics Market, by Disease Area
11.2.22 France Molecular Diagnostics Market, by Technology
11.2.22.1 France Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.23 France Molecular Diagnostics Market, by Product and Services
11.2.24 France Molecular Diagnostics Market, by End User
11.2.25 Italy
11.2.25.1 Overview
11.2.26 Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.27 Italy Molecular Diagnostics Market, by Disease Area
11.2.28 Italy Molecular Diagnostics Market, by Technology
11.2.28.1 Italy Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.29 Italy Molecular Diagnostics Market, by Product and Services
11.2.30 Italy Molecular Diagnostics Market, by End User
11.2.31 Spain
11.2.31.1 Overview
11.2.32 Spain Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.33 Spain Molecular Diagnostics Market, by Disease Area
11.2.34 Spain Molecular Diagnostics Market, by Technology
11.2.34.1 Spain Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.34.1.1 Spain Molecular Diagnostics Market, by Product and Services
11.2.35 Spain Molecular Diagnostics Market, by End User
11.2.36 Rest of Europe
11.2.36.1 Overview
11.2.37 Rest of Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.38 Rest of Europe Molecular Diagnostics Market, by Disease Area
11.2.39 Rest of Europe Molecular Diagnostics Market, by Technology
11.2.39.1 Rest of Europe Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.40 Rest of Europe Molecular Diagnostics Market, by Product and Services
11.2.41 Rest of Europe Molecular Diagnostics Market, by End User
11.3 Asia Pacific Molecular Diagnostics Market, Revenue And Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific Molecular Diagnostics Market, by Disease Area
11.3.4 Asia Pacific Molecular Diagnostics Market, by Technology
11.3.4.1 Asia Pacific Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.5 Asia Pacific Molecular Diagnostics Market, by Product and Services
11.3.6 Asia Pacific Molecular Diagnostics Market, by End User
11.3.6.1 Asia Pacific Molecular Diagnostics Market by Country
11.3.7 China
11.3.7.1 Overview
11.3.8 China Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.9 China Molecular Diagnostics Market, by Disease Area
11.3.10 China Molecular Diagnostics Market, by Technology
11.3.10.1 China Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.11 China Molecular Diagnostics Market, by Product and Services
11.3.12 China Molecular Diagnostics Market, by End User
11.3.13 Japan
11.3.13.1 Overview
11.3.14 Japan Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.15 Japan Molecular Diagnostics Market, by Disease Area
11.3.16 Japan Molecular Diagnostics Market, by Technology
11.3.16.1 Japan Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.17 Japan Molecular Diagnostics Market, by Product and Services
11.3.18 Japan Molecular Diagnostics Market, by End User
11.3.19 India
11.3.19.1 Overview
11.3.20 India Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.21 India Molecular Diagnostics Market, by Disease Area
11.3.22 India Molecular Diagnostics Market, by Technology
11.3.22.1 India Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.23 India Molecular Diagnostics Market, by Product and Services
11.3.24 India Molecular Diagnostics Market, by End User
11.3.25 Australia
11.3.25.1 Overview
11.3.26 Australia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.27 Australia Molecular Diagnostics Market, by Disease Area
11.3.28 Australia Molecular Diagnostics Market, by Technology
11.3.28.1 Australia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.29 Australia Molecular Diagnostics Market, by Product and Services
11.3.30 Australia Molecular Diagnostics Market, by End User
11.3.31 South Korea
11.3.31.1 Overview
11.3.32 South Korea Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.33 South Korea Molecular Diagnostics Market, by Disease Area
11.3.34 South Korea Molecular Diagnostics Market, by Technology
11.3.34.1 South Korea Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.35 South Korea Molecular Diagnostics Market, by Product and Services
11.3.36 South Korea Molecular Diagnostics Market, by End User
11.3.37 Singapore
11.3.37.1 Overview
11.3.38 Singapore Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.39 Singapore Molecular Diagnostics Market, by Disease Area
11.3.40 Singapore Molecular Diagnostics Market, by Technology
11.3.40.1 Singapore Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.41 Singapore Molecular Diagnostics Market, by Product and Services
11.3.42 Singapore Molecular Diagnostics Market, by End User
11.3.43 Malaysia
11.3.43.1 Overview
11.3.44 Malaysia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.45 Malaysia Molecular Diagnostics Market, by Disease Area
11.3.46 Malaysia Molecular Diagnostics Market, by Technology
11.3.46.1 Malaysia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.47 Malaysia Molecular Diagnostics Market, by Product and Services
11.3.48 Malaysia Molecular Diagnostics Market, by End User
11.3.49 Philippines
11.3.49.1 Overview
11.3.50 Philippines Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.51 Philippines Molecular Diagnostics Market, by Disease Area
11.3.52 Philippines Molecular Diagnostics Market, by Technology
11.3.52.1 Philippines Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.53 Philippines Molecular Diagnostics Market, by Product and Services
11.3.54 Philippines Molecular Diagnostics Market, by End User
11.3.55 Thailand
11.3.55.1 Overview
11.3.56 Thailand Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.57 Thailand Molecular Diagnostics Market, by Disease Area
11.3.58 Thailand Molecular Diagnostics Market, by Technology
11.3.58.1 Thailand Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.59 Thailand Molecular Diagnostics Market, by Product and Services
11.3.60 Thailand Molecular Diagnostics Market, by End User
11.3.61 Indonesia
11.3.61.1 Overview
11.3.62 Indonesia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.63 Indonesia Molecular Diagnostics Market, by Disease Area
11.3.64 Indonesia Molecular Diagnostics Market, by Technology
11.3.64.1 Indonesia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.65 Indonesia Molecular Diagnostics Market, by Product and Services
11.3.66 Indonesia Molecular Diagnostics Market, by End User
11.3.67 Vietnam
11.3.67.1 Overview
11.3.68 Vietnam Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.69 Vietnam Molecular Diagnostics Market, by Disease Area
11.3.70 Vietnam Molecular Diagnostics Market, by Technology
11.3.70.1 Vietnam Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.71 Vietnam Molecular Diagnostics Market, by Product and Services
11.3.72 Vietnam Molecular Diagnostics Market, by End User
11.3.73 Rest of Asia Pacific
11.3.73.1 Overview
11.3.74 Rest of Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.75 Rest of Asia Pacific Molecular Diagnostics Market, by Disease Area
11.3.76 Rest of Asia Pacific Molecular Diagnostics Market, by Technology
11.3.76.1 Rest of Asia Pacific Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.77 Rest of Asia Pacific Molecular Diagnostics Market, by Product and Services
11.3.78 Rest of Asia Pacific Molecular Diagnostics Market, by End User
11.4 Middle East & Africa Molecular Diagnostics Market, Revenue And Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa Molecular Diagnostics Market, by Disease Area
11.4.4 Middle East & Africa Molecular Diagnostics Market, by Technology
11.4.4.1 Middle East & Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.4.5 Middle East & Africa Molecular Diagnostics Market, by Product and Services
11.4.6 Middle East & Africa Molecular Diagnostics Market, by End User
11.4.6.1 Middle East & Africa Molecular Diagnostics Market by Country
11.4.7 UAE
11.4.7.1 Overview
11.4.8 UAE Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.4.9 UAE Molecular Diagnostics Market, by Disease Area
11.4.10 UAE Molecular Diagnostics Market, by Technology
11.4.10.1 UAE Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.4.11 UAE Molecular Diagnostics Market, by Product and Services
11.4.12 UAE Molecular Diagnostics Market, by End User
11.4.13 Saudi Arabia
11.4.13.1 Overview
11.4.14 Saudi Arabia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.4.15 Saudi Arabia Molecular Diagnostics Market, by Disease Area
11.4.16 Saudi Arabia Molecular Diagnostics Market, by Technology
11.4.16.1 Saudi Arabia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.4.17 Saudi Arabia Molecular Diagnostics Market, by Product and Services
11.4.18 Saudi Arabia Molecular Diagnostics Market, by End User
11.4.19 South Africa
11.4.19.1 Overview
11.4.20 South Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.4.21 South Africa Molecular Diagnostics Market, by Disease Area
11.4.22 South Africa Molecular Diagnostics Market, by Technology
11.4.22.1 South Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.4.23 South Africa Molecular Diagnostics Market, by Product and Services
11.4.24 South Africa Molecular Diagnostics Market, by End User
11.4.25 Rest of Middle East & Africa
11.4.25.1 Overview
11.4.26 Rest of Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.4.27 Rest of Middle East & Africa Molecular Diagnostics Market, by Disease Area
11.4.28 Rest of Middle East & Africa Molecular Diagnostics Market, by Technology
11.4.28.1 Rest of Middle East & Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.4.29 Rest of Middle East & Africa Molecular Diagnostics Market, by Product and Services
11.4.30 Rest of Middle East & Africa Molecular Diagnostics Market, by End User
11.5 South & Central America Molecular Diagnostics Market, Revenue And Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America Molecular Diagnostics Market, by Disease Area
11.5.4 South & Central America Molecular Diagnostics Market, by Technology
11.5.4.1 South & Central America Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.5.5 South & Central America Molecular Diagnostics Market, by Product and Services
11.5.6 South & Central America Molecular Diagnostics Market, by End User
11.5.6.1 South & Central America Molecular Diagnostics Market by Country
11.5.7 Brazil
11.5.7.1 Overview
11.5.8 Brazil Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.5.9 Brazil Molecular Diagnostics Market, by Disease Area
11.5.10 Brazil Molecular Diagnostics Market, by Technology
11.5.10.1 Brazil Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.5.11 Brazil Molecular Diagnostics Market, by Product and Services
11.5.12 Brazil Molecular Diagnostics Market, by End User
11.5.13 Argentina
11.5.13.1 Overview
11.5.14 Argentina Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.5.15 Argentina Molecular Diagnostics Market, by Disease Area
11.5.16 Argentina Molecular Diagnostics Market, by Technology
11.5.16.1 Argentina Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.5.17 Argentina Molecular Diagnostics Market, by Product and Services
11.5.18 Argentina Molecular Diagnostics Market, by End User
11.5.19 Rest of South & Central America
11.5.19.1 Overview
11.5.20 Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.5.21 Rest of South & Central America Molecular Diagnostics Market, by Disease Area
11.5.22 Rest of South & Central America Molecular Diagnostics Market, by Technology
11.5.22.1 Rest of South & Central America Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.5.23 Rest of South & Central America Molecular Diagnostics Market, by Product and Services
11.5.24 Rest of South & Central America Molecular Diagnostics Market, by End User
12. Pre & Post Covid-19 Impact
12.1 Pre & Post Covid-19 Impact
13. Molecular Diagnostics Market Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Molecular Diagnostics Market, Key Company Profiles
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Agilent Technologies Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 F. Hoffmann-La Roche Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Qiagen NV
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 bioMerieux SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Illumina Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Danaher
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Siemens Healthineers AG
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Novartis AG
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 TBG Diagnostics Limited
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
15. Appendix
15.1 About Us
15.2 Glossary of Terms
List of Tables
Table 1. Molecular Diagnostics Market Segmentation
Table 2. North America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 3. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 4. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 5. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 6. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – End User
Table 7. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 8. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 9. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 10. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 11. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 12. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 13. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 14. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 15. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 16. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 17. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 18. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 19. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 20. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 21. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 22. Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 23. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 24. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 25. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 26. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – End User
Table 27. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Disease Area
Table 28. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 29. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 30. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 31. Germany Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 32. UK Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 33. UK Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 34. UK Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 35. UK Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 36. UK Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 37. France Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 38. France Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 39. France Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 40. France Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 41. France Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 42. Italy Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 43. Italy Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 44. Italy Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 45. Italy Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 46. Italy Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 47. Spain Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 48. Spain Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 49. Spain Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 50. Spain Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 51. Spain Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 52. Rest of Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 53. Rest of Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 54. Rest of Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 55. Rest of Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 56. Rest of Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 57. Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 58. Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 59. Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 60. Asia PAcific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 61. Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – End User
Table 62. China Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 63. China Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 64. China Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 65. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 66. China Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 67. Japan Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 68. Japan Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 69. Japan Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 70. Japan Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 71. Japan Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 72. India Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 73. India Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 74. India Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 75. India Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 76. India Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 77. Australia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 78. Australia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 79. Australia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 80. Australia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 81. Australia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 82. South Korea Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 83. South Korea Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 84. South Korea Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 85. South Korea Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 86. South Korea Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 87. Singapore Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 88. Singapore Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 89. Singapore Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 90. Singapore Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 91. Singapore Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – End User
Table 92. Malaysia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 93. Malaysia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 94. Malaysia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 95. Malaysia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 96. Malaysia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 97. Philippines Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 98. Philippines Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 99. Philippines Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 100. Philippines Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 101. Philippines Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 102. Thailand Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 103. Thailand Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 104. Thailand Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 105. Thailand Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 106. Thailand Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 107. Indonesia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 108. Indonesia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 109. Indonesia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 110. Indonesia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 111. Indonesia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 112. Vietnam Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 113. Vietnam Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 114. Vietnam Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 115. Vietnam Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 116. Vietnam Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 117. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 118. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 119. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 120. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 121. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 122. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 123. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 124. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 125. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 126. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – End User
Table 127. UAE Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 128. UAE Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 129. UAE Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 130. UAE Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 131. UAE Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 132. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 133. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 134. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 135. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 136. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 137. South Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 138. South Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 139. South Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 140. South Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 141. South Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 142. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 143. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 144. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 145. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 146. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 147. South & Central America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 148. South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 149. South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 150. South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 151. South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – End User
Table 152. Brazil Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 153. Brazil Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 154. Brazil Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 155. Brazil Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 156. Brazil Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 157. Argentina Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 158. Argentina Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 159. Argentina Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 160. Argentina Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 161. Argentina Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 162. Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) – Disease Area
Table 163. Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Technology
Table 164. Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 165. Rest of South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 166. Rest of South & Central America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 167. Organic Developments Done By Companies
Table 168. Inorganic Developments Done By Companies
Table 169. Glossary of Terms, Molecular Diagnostics Market
List of Figures
Figure 1. North America - PEST Analysis
Figure 2. Europe - PEST Analysis
Figure 3. Asia Pacific - PEST Analysis
Figure 4. South & Central America - PEST Analysis
Figure 5. Middle East & Africa - PEST Analysis
Figure 6. Molecular Diagnostics Market - Key Industry Dynamics
Figure 7. Impact Analysis of Drivers and Restraints
Figure 8. Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
Figure 9. Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
Figure 10. Oncology: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Infectious Disease: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Infectious Disease: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiac Diseases: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Immune System Disorders: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 17. PCR: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. RT-PCR: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. qPCR: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Multiplex PCR: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Isothermal Nucleic Acid Amplification Technology (INAAT): Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. DNA Sequencing and Next-Generation Sequencing (NGS): Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. DNA microarrays: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. In-Situ Hybridization (ISH): Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 28. Assays and Kits: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Instruments: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Services and Software: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 32. Hospitals and Clinics: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Ambulatory Surgical Centers: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Research and Academic Institutes: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Others: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Molecular Diagnostics Market, 2022 ($Mn)
Figure 37. North America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 38. North America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 39. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 40. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 41. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 42. Europe Molecular Diagnostics Market, By Geography, 2022 ($Mn)
Figure 43. Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 44. Europe Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 45. Germany Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 46. UK Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 47. France Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 48. Italy Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 49. Spain Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 50. Rest of Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 51. Molecular Diagnostics Market, By Geography, 2022 ($Mn)
Figure 52. Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 53. Asia Pacific Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 54. China Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 55. Japan Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 56. India Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 57. Australia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 58. South Korea Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 59. Singapore Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 60. Malaysia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 61. Philippines Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 62. Thailand Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 63. Indonesia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 64. Vietnam Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 65. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 66. Molecular Diagnostics Market, By Geography, 2022 And 2030 ($Mn)
Figure 67. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 68. Middle East & Africa Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 69. UAE Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 70. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 71. South Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 72. Rest of Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 73. Molecular Diagnostics Market, By Geography, 2022 ($Mn)
Figure 74. South & Central America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 75. South & Central America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
Figure 76. Brazil Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 77. Argentina Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
Figure 78. Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 79. Pre & Post Covid-19 Impact
Figure 80. Growth Strategies Done by the Companies in the Market (%)
The List of Companies - Molecular Diagnostics Market
- Abbott Laboratories
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc
- F. Hoffman-La Roche Ltd.
- Qiagen NV
- bioMerieux SA
- Illumnia Inc.
- Danaher
- Siemens Healthineers AG
- Novartis AG
- TBG Diagnostics Limited
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For